For human succinic semialdehyde dehydrogenase, reversible disulfide bond formation of the active site cysteine (Cys 340 ) and an adjacent residue (Cys 342 ) was described as regulatory redox-switch mechanism
Retatrutide is being studied as a triple-receptor medication that targets GIP, GLP-1, and glucagon receptors
The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways
10.1038/s41392-024-01931-z Summary Keywords glucagon-like peptide-1 receptor, diabetes mellitus, -cell, insulin secretion, blood glucose Citation Li S, Huang N, Wang M, Huang W, Luo Y and Huang J (2025) GLP-1R in diabetes mellitus: from basic discovery to therapeutics development
Well, I do think that you dont want to see your blood cholesterol going crazy high because that can be a sign that youre not using it well